EUVIMEDEUVIMED entdecken
Vergleichsstudie

The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes

Reiki Nishimura, Yoshitaka Fujiki, Tetsuhiko Taira, Toshiko Miyaki, Shuichi Kanemitsu, Daisuke Yotsumoto, Megumi Teraoka, Junko Kawano, Naomi Gondo, Reiko Mitsueda, Shinichi Baba, Yasuyo Ohi und 3 weitere

Clinical Breast Cancer · 2024-07 · 24 (5) · 431-438

DOI: 10.1016/j.clbc.2024.02.013 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Breast Cancer, 2024-07. Verfasst von Reiki Nishimura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan. Electronic address:…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansFemalePrognosisRetrospective StudiesMiddle AgedAdultAgedBiomarkers, TumorReceptors, EstrogenNeoplasm StagingNeoplasm Recurrence, LocalAged, 80 and overSurvival Rate

Stichwörter der Autor:innen

Factors for survivalNeoadjuvant chemotherapyPathological complete responseRecurrenceSurvival

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorReceptors, EstrogenERBB2 protein, human

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan. Electronic address: nishirei@ymail.ne.jp.
  • Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
  • Clinical Oncology and Pathology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
  • Pathology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.

Zitieren

APA

Nishimura, R., Fujiki, Y., Taira, T., Miyaki, T., Kanemitsu, S., Yotsumoto, D., Teraoka, M., Kawano, J., Gondo, N., Mitsueda, R., Baba, S., Ohi, Y., Rai, Y., Sagara, Y., & Sagara, Y. (2024). The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes. Clinical Breast Cancer, 24(5), 431-438. https://doi.org/10.1016/j.clbc.2024.02.013

Vancouver

Nishimura R, Fujiki Y, Taira T, Miyaki T, Kanemitsu S, Yotsumoto D, et al. The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes. Clinical Breast Cancer. 2024;24(5):431-438. doi:10.1016/j.clbc.2024.02.013

BibTeX
@article{Nishimura2024,
  author = {Nishimura, Reiki and Fujiki, Yoshitaka and Taira, Tetsuhiko and Miyaki, Toshiko and Kanemitsu, Shuichi and Yotsumoto, Daisuke and Teraoka, Megumi and Kawano, Junko and Gondo, Naomi and Mitsueda, Reiko and Baba, Shinichi and Ohi, Yasuyo and Rai, Yoshiaki and Sagara, Yoshiaki and Sagara, Yasuaki},
  title = {The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes},
  journal = {Clinical Breast Cancer},
  year = {2024},
  volume = {24},
  number = {5},
  pages = {431--438},
  doi = {10.1016/j.clbc.2024.02.013}
}
Kostenlos starten →